Pityriasis Rosea • Pityriasis Rotunda • Granular Parakeratosis SMALL PLAQUE PARAPSORIASIS

Pityriasis Rosea • Pityriasis Rotunda • Granular Parakeratosis SMALL PLAQUE PARAPSORIASIS

Papulo-Squamous Disorders Papulo-Squamous Disorders • Small Plaque Parapsoriasis • Large Plaque Parapsoriasis • Pityriasis Lichenoides Et Varioliformis Acuta & Pityriasis Lichenoides Chronica • Pityriasis Rubra Pilaris • Pityriasis Rosea • Pityriasis Rotunda • Granular Parakeratosis SMALL PLAQUE PARAPSORIASIS • Chronic, asymptomatic, erythematous scaly patches. Lesions are generally <5 cm in diameter or digitate. • Histologically, mild, nonspecific spongiotic dermatitis with parakeratosis is seen • CD4+ T cells predominance in the lymphocytic infiltrate • A dominant T-cell clonality is demonstrable in some cases. • This group is significant for the tendency of its disorders to coexist or overlap with one another and for its association with lymphomas. • Small plaque parapsoriasis typically presents as round–oval patches that are generally <5 cm in diameter. • They are variably erythematous (but often less intense than psoriasis) and covered with a fine scale. • Variants: • Xanthoerythrodermia perstans: yellow hue • Digitate dermatosis: – Elongated – Finger-like patches – Symmetrically distributed – On the flanks. LARGE PLAQUE PARAPSORIASIS • Chronic, asymptomatic, erythematous scaly patches • Lesions are generally >5 cm in diameter • Histologically, a nonspecific spongiotic dermatitis or an interface lymphocytic infiltrate with a variable degree of lichenoid features is seen • CD4+ T cells predominance in the lymphocytic infiltrate • A dominant T-cell clonality is demonstrable in many cases • It is thought that large plaque parapsoriasis represents the earliest stage of mycosis fungoides • Variably erythematous, round or irregularly shaped, scaly patches that are >5 cm in diameter. • They may or may not exhibit the clinical triad of atrophy, telangiectasia, and hyper/hypopigmentation (poikiloderma vasculare atrophicans). • Variant: “Retiform parapsoriasis” • Syn. Parapsoriasis variegata, parakeratosis variegata or parapsoriasis lichenoides. • Rare variant. • Widespread, ill-defined patches in a net-like or zebra-stripe pattern. • It progress to overt MF. PLEVA & PLC • Pityriasis Lichenoides Et Varioliformis Acuta & Pityriasis Lichenoides Chronica • Mucha–Habermann disease (PLEVA) • Guttate Parapsoriasis (PLC) • PLEVA & PLC are two ends of a disease spectrum. • Both entities are characterized by: – Recurrent crops of spontaneously regressing erythematous papules. – PLEVA: Crusted and occasionally vesiculopustular. – PLC they are scaly. • Individual patients may show intermediate or mixed lesions. PLEVA: A, B, C PLC: D Overlap: E Overlap PI Hypopigmentation PITYRIASIS RUBRA PILARIS (PRP) • Follicular papules with an erythematous base are a characteristic finding, including on the proximal dorsal fingers. • Coalescence of orange–red plaques, but with obvious islands of sparing. • ±An orange–red waxy palmoplantar keratoderma. • Six types described, the classic adult form is the most common. • The classic types (adult and juvenile) typically resolve within 3–5 years. Treatment of PRP • Oral Vitamin A: – Successful treatment – Sometimes in combination with vitamins B and D. • Systemic retinoids: – Isotretinoin: 1–1.5 mg/kg/day (3-6 ms) – Acitretin – Alitretinoin – Effect of retinoids on familial PRP appears less certain. • Methotrexate: – Significant clinical improvement of PRP. – Weekly oral or SC doses of 10–25 mg (3-6 ms). • Combinations (MTX+AcitrEtin): – In severe cases – MTX: (5–30 mg/week) plus Acitretin. – Simultaneously or add after inadequate response. – Increased risk for hepatotoxicity. • Biologic: – Case reports & small case series. – TNF-α inhibitors (etanercept, infliximab, adalimumab), secukinumab and ustekinumab). • Other potential therapies: – Systemic immunosuppressives (e.g. azathioprine, prednisone, cyclosporine) – Success with narrowband UVB, UVA1, or PUVA in combination with an oral retinoid – ?? one patient with UVB-provoked PRP. PITYRIASIS ROSEA • A self-limited papulosquamous eruption that is occasionally pruritic. • Primarily in adolescents and young adults, favoring the trunk and proximal extremities. • Herald patch followed by lesions that are usually oval in shape and oriented with their long axes along Langer cleavage lines • Less common variants include inverse, vesicular, purpuric, and pustular Differential Diagnosis • 2ry Syphilis. • Drug eruptions: that can mimic pityriasis rosea; (ACE inhibitors, β-blockers, Metronidazole, and isotretinoin, Arsenic, Bismuth, Gold, Barbiturates, Clonidine, Hydrochlorothiazide, Omeprazole, Terbinafine, TNF-α inhibitors, NSAIDs & multiple vaccines). • A drug-induced pityriasis rosea-like eruption is often slower to resolve. • The herald patch or generalized eruption: – Tinea corporis – Tinea versicolor – Nummular dermatitis. • Vesicular pityriasis rosea vs Guttate psoriasis • Papulosquamous disorders such as pityriasis lichenoides. Treatment • Asymptomatic and self-limited: – Patient education and reassurance. • Pruritus: – Counterirritant antipruritic lotions – Low- to medium-strength topical corticosteroids. • More severe cases: – UVB phototherapy (broadband or narrowband) – Natural sunlight exposure and oral antihistamines. – Rarely, a brief course of systemic corticosteroids. • In a double-blind, placebo-controlled trial, 73% of patients had complete resolution after receiving 14 days of erythromycin in divided doses. The placebo group showed no resolution over the same time. • In a bilateral comparison trial of UVB, a reduction in severity, but not pruritus or duration, was observed. • One non-randomized study reported that acyclovir (800 mg five times daily for 1 week) led to a faster resolution of lesions and fewer new lesions. PITYRIASIS ROTUNDA • Asymptomatic dermatosis seen primarily in the Far East and Mediterranean basin and in individuals of African descent. • Large circular and polycyclic scaly patches with sharp margins and no evidence of inflammation clinically. • Mostly, lesions are hyperpigmented and localized to the trunk and extremities. • A hypopigmented halo in some patients, and sometimes the entire lesion is hypopigmented. • 2 groups: • Type I: – In blacks and Asians – Hyperpigmented, in association with an internal malignancy, no family history. • Type II: – In Caucasians – Numerous (>30) lesions; a family history no internal malignancy. • Histologic features are similar to those of ichthyosis vulgaris, raising the possibility of an unusual form of ichthyosis. • In some patients it may be associated with malnutrition, mycobacterial infections, and/or underlying malignancies, while in others it is familial. Differential Diagnosis • Tinea Corporis • Tinea Versicolor • Leprosy • Large Plaque Parapsoriasis. • Progressive Macular Hypomelanosis Treatment • Relatively difficult to treat. • Trials with topical lactic acid, urea, tars, emollients, and corticosteroids have provided little benefit. • Topical Tretinoin cream 0.1% can result in modest improvement. • Systemic Retinoids: extensive disease • Reversal of any underlying disorder. GRANULAR PARAKERATOSIS • Synonyms: – Axillary granular parakeratosis, Intertriginous granular Parakeratosis. • The primary lesions are pruritic brownish-red keratotic papules that can coalesce into plaques. • The adult form: occurs almost exclusively in women. • Localized to the axillae, but other intertriginous sites can be affected. • The infantile form: is associated with diaper wearing as bilateral plaques in the inguinal folds or erythematous geometric plaques underlying pressure points from the diaper. • Histopathologically, there is distinct retention of basophilic keratohyaline granules within areas of parakeratosis in the stratum corneum. • A defect in processing profilaggrin to filaggrin is a proposed mechanism. Differential Diagnosis • Common causes of intertrigo: – Seborrheic dermatitis – Candidiasis – Inverse psoriasis – Erythrasma – Hailey–Hailey disease, Darier disease, P. vegetans • Seborrheic keratoses • Acanthosis nigricans. • Irritant Allergic Contact Dermatitis. Treatment • Based upon case reports and small series, therapeutic success has been reported: – Topical corticosteroids – Vitamin D analogues – Retinoids – Cryotherapy – Oral isotretinoin and oral antifungals • Spontaneous resolution has also been observed (including in infants), as have relapses. .

View Full Text

Details

  • File Type
    pdf
  • Upload Time
    -
  • Content Languages
    English
  • Upload User
    Anonymous/Not logged-in
  • File Pages
    42 Page
  • File Size
    -

Download

Channel Download Status
Express Download Enable

Copyright

We respect the copyrights and intellectual property rights of all users. All uploaded documents are either original works of the uploader or authorized works of the rightful owners.

  • Not to be reproduced or distributed without explicit permission.
  • Not used for commercial purposes outside of approved use cases.
  • Not used to infringe on the rights of the original creators.
  • If you believe any content infringes your copyright, please contact us immediately.

Support

For help with questions, suggestions, or problems, please contact us